Review
Version 1
Preserved in Portico This version is not peer-reviewed
Linoleic Acid Derivative DCP-LA Prevents Tau Phosphorylation by Targeting GSK-3β
Version 1
: Received: 17 January 2018 / Approved: 17 January 2018 / Online: 17 January 2018 (05:26:21 CET)
How to cite: Nishizaki, T. Linoleic Acid Derivative DCP-LA Prevents Tau Phosphorylation by Targeting GSK-3β. Preprints 2018, 2018010148. https://doi.org/10.20944/preprints201801.0148.v1 Nishizaki, T. Linoleic Acid Derivative DCP-LA Prevents Tau Phosphorylation by Targeting GSK-3β. Preprints 2018, 2018010148. https://doi.org/10.20944/preprints201801.0148.v1
Abstract
Abnormal Tau phosphorylation and aggregation into neuronal paired helical filaments and neurofibrillary tangles cause tauopathies, a class of neurodegenerative diseases, that include Alzheimer’s disease, frontotemporal dementia and parkinsonism linked to chromosome 17, progressive supranuclear palsy, Pick's disease, and corticobasal degeneration. Glycogen synthase kinase-3β (GSK-3β) is the most critical kinase to phosphorylate Tau. We have developed the linoleic acid derivative 8-[2-(2-pentyl-cyclopropylmethyl)-cyclopropyl]-octanoic acid (DCP-LA), with cyclopropane rings instead of cis-double bonds, as an anti-dementia drug. DCP-LA serves as a selective activator of PKCε and a potent inhibitor of protein tyrosine phosphatase 1B (PTP1B). DCP-LA prevents Tau phosphorylation due to PKCε-mediated direct inactivation of GSK-3β, to PKCε/Akt-mediated inactivation of GSK-3β, and to receptor tyrosine kinase-mediated inactivation of GSK-3β in association with PTP1B inhibition. DCP-LA targeting GSK-3β, thus, could become a valid drug for treatment of tauopathies.
Keywords
DCP-LA; PKCε; protein tyrosine phosphatase 1B; Akt; GSK-3β; tauopathy
Subject
Biology and Life Sciences, Biochemistry and Molecular Biology
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment